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cantime in a short course was comparable with standard-course
regimen.
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ects between the age 8 and 14 years than subjects below 8 years of
ge. Results from other endemic areas of the state showed similar
rends.
Conclusion: The results conﬁrmed that Ebonyi State is highly
ndemic for urinary schistosomiasis
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revalence of urinary schistosomiasis and bacteriuria co-
nfection among school age children (5-15years) in Amagunze,
outheastern Nigeria, 2011
. Ossai
Nigerian Field Epidemiology and Laboratory Training Pro-
ramme(NFELTP), Abuja, Nigeria
Background: Amagunze is a rice producing community in
outheasternNigeria known for high prevalence of urinary schisto-
omiasis (79% according to a study in 1989). Recently studies have
mplicated co-infection with bacteriuria in the aetiology of bladder
ancer. Unfortunately knowledge about co-infection of bacteriuria
nd urinary schistosomiasis in this age group(5-15years) who are
ostly at risk is not available. We investigated the current preva-
ence of urinary schistosomiasis and co-infection with bacteriuria
n this community
Methods: A cross-sectional survey in which 3 primary
chools(A, B and C) were randomly selected from 15 in Ama-
unze. Four classes were randomly selected from each school and
he whole class enrolled in the study. Altogether 309 pupils were
nrolled. About 20mls of urine samples were collected by subjects
hemselves between 10:00am and 3:00pm.Each sample collected
as divided into 2(X & Y fractions). Urinalysis and microscopy
ere conducted with fraction X for ova and intensity while Y was
ultured for bacteriuria. Signiﬁcant bacteriuria was deﬁned as 2
r more consecutive urine cultures showing >105CFU/ml. Inten-
ity was categorized as light(<50 ova/10mls of urine) or heavy(>50
va/10mls of urine). Ethical approvals were got from relevant
uthorities. Consent of parents and pupils was obtained. Question-
aire was administered on pupils for data on socio-economic and
isk factors.
Results: Of 309 pupils tested, 133(43.04%) had urinary
chistosomiasis (CI = 37.6%-48.6%). Sex-speciﬁc prevalence was
ales73/151, females60/158(X2=3.4, 1df). Infection rates in
he 3 schools (A, B, C) were 68/103, 37/101 and 28/105
espectively(X2=35.4, 2df). Bacteriuria co-infection rate was
4/133(18%)(CI = 12.2-25.3%). Heavy infection was 76.7%. Of
33infected pupils 85% admitted swimming in open water.
Conclusion: There was high prevalence of both urinary schis-
osomiasis and bacteriuria co-infection. This may lead to increased
ases of bladder cancer if co-treatment is offered to cases.
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A Comparison of different regimens of meglumine antimoniate
in the treatment of visceral leishmaniasis, Southern Iran
G. Pouladfar ∗, F. Falahi, Z. Jafarpoor
Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of
Background: Visceral leishmaniasis (VL) or Kala-azar, a life-
threatening parasitic infection, is the most frequent among the
rural population and nomads in Northwest and southern Iran.
Antimony (meglumine antimoniate) has been the therapeutic cor-
nerstone which has been used in different regimens. This study
was conducted to evaluate the different regimens ofmeglumine
antimoniate (Glucantime) in VL patients, Southern Iran.
Methods: In a retrospective cohort study, clinical response
deﬁned as defervescence was evaluated among patients who
received different doses of Glucantime; the rate of relapse in
patients treated with two different duration of Glucantime treat-
ment was compared, too. The hospital charts of the all VL patients
admitted in Namazi Hospital, a tertiary referral hospital afﬁliated
to Shiraz University ofMedical Sciences, from 1997-2006 reviewed
and data collected in a questionnaire.
Results: The mean age was 24.5 mo. The initial antileismanial
regimen was Glucantime in 258 (85.5%) patients and amphotericin
B in 44 (15.5%) patients. The mean day of defervesce after starting
treatment was 3.7 days in 174 patients who received 7-10mg of
Glucantime per kg of body weight per day (low-dose), 2.8 in 24
patients treated with 12-18mg/kg/day and 4.2 days in 60 patients
treated with 20mg/kg/day or more (P =0.51).
Duration of Glucantime treatment was determined in 109
patients. The majority, 61 patients (56%), was treated for more
than 3 weeks (standard conventional regimen) and in 48 patients
(44%), Glucantime was continued for seven days after deferves-
cence (short-course regimen). Relapse was detected in 4 (8.3%)
patients treated with short-course regimen and in 3 (4.9%) patients
treated with standard course (P =0.49).
Conclusion: In southern Iran, clinical response to low-dose Glu-
cantime regimen seems to be the same as the regimenswith higher
doses and the rate of relapse in patients who treated with Glu-
